https://www.selleckchem.com/pr....oducts/yap-tead-inhi
Distinguishing hypertrophic cardiomyopathy (HCM) from left ventricular hypertrophy (LVH) due to systematic training (athlete's heart, AH) from morphologic assessment remains challenging. The purpose of this study was to examine the role of T2 mapping and deformation imaging obtained by cardiovascular magnetic resonance (CMR) to discriminate AH from HCM with (HOCM) or without outflow tract obstruction (HNCM). Thirty-three patients with HOCM, 9 with HNCM, 13 strength-trained athletes as well as individual age- and
Like
Comment
Share
